pamabrom - PMC

Result Filters

You searched 8+ million full text articles

Try this search in 34+ million citations and abstracts

PMC Full-Text Search Results

Items: 1 to 20 of 27

<< First< Prev

Page of 2

Next >Last >>

Select item 37846531.

Epithelial-Mesenchymal Transition Enhances Nano-scale Actin Filament Dynamics of Ovarian Cancer Cells

Sunyoung Lee, Yang Yang, David Fishman, Mark M. Banaszak Holl, Seungpyo Hong

J Phys Chem B. Author manuscript; available in PMC 2014 Aug 8.

Published in final edited form as: J Phys Chem B. 2013 Aug 8; 117(31): 9233–9240. Published online 2013 Jul 26. doi: 10.1021/jp4055186

PMCID:: PMC3784653

Article PDF–2.2M

Select item 40908262.

Development and Validation of Stability-indicating RP-HPLC Method for Estimation of Pamabrom in Tablets

U. Shah, M. Kavad, M. Raval

Indian J Pharm Sci. 2014 May-Jun; 76(3): 198–202.

PMCID:: PMC4090826

Article PDF–648K

Select item 37716703.

RP-LC and TLC Densitometric Determination of Paracetamol and Pamabrom in Presence of Hazardous Impurity of Paracetamol and Application to Pharmaceuticals

Ola Mohamed El-Houssini

Anal Chem Insights. 2013; 8: 73–81. Published online 2013 Sep 5. doi: 10.4137/ACI.S12349

PMCID:: PMC3771670

Article PDF–532K

Select item 98946474.

Fixed Dose Versus Loose Dose: Analgesic Combinations

Joseph Pergolizzi, Giustino Varrassi, Jo Ann K LeQuang, Frank Breve, Peter Magnusson

Cureus. 2023 Jan; 15(1): e33320. Published online 2023 Jan 3. doi: 10.7759/cureus.33320

PMCID:: PMC9894647

Article PDF–251K

Select item 93772305.

Research Poster Abstracts

Can J Pain. 2022; 6(3): A60–A180. Published online 2022 Aug 12. doi: 10.1080/24740527.2022.2088027

Retraction in:: Can J Pain. 2024; 8(1): 2337608.

PMCID:: PMC9377230

Article

Select item 101337036.

Synergistic interaction and activation of the opioid receptor-NO–cGMP–K⁺ channel pathway on peripheral antinociception induced by the α-Bisabolol-diclofenac combination

Mario I. Ortiz

Front Pharmacol. 2023; 14: 1158236. Published online 2023 Apr 13. doi: 10.3389/fphar.2023.1158236

PMCID:: PMC10133703

Article PDF–1.5M

Select item 57464307.

REASONS WOMEN DO NOT SEEK HEALTH CARE FOR DYSMENORRHEA

Chen X. Chen, Carol Shieh, Claire B. Draucker, Janet S. Carpenter

J Clin Nurs. Author manuscript; available in PMC 2019 Jan 1.

Published in final edited form as: J Clin Nurs. 2018 Jan; 27(1-2): e301–e308. Published online 2017 Sep 7. doi: 10.1111/jocn.13946

PMCID:: PMC5746430

Article PDF–157K

Select item 66617578.

Analytical methods for the determination of paracetamol, pseudoephedrine and brompheniramine in Comtrex tablets

Souha Hosam Youssef, Dalia Mohamed, Maha Abdel Monem Hegazy, Amr Badawey

BMC Chem. 2019 Dec; 13(1): 78. Published online 2019 Jul 2. doi: 10.1186/s13065-019-0595-6

PMCID:: PMC6661757

Article PDF–1.3M

Select item 97175649.

Validated HPLC–PDA methodology utilized for simultaneous determination of Etoricoxib and Paracetamol in the presence of Paracetamol toxic impurities

Mona A. Abdel Rahman, Mohamed R. Elghobashy, Hala E. Zaazaa, Shimaa A. Atty, Sally S. El-Mosallamy

BMC Chem. 2022 Dec; 16(1): 108. Published online 2022 Dec 2. doi: 10.1186/s13065-022-00904-z

PMCID:: PMC9717564

Article PDF–876K

Select item 948666510.

Assessment of quality of life and effect of non-pharmacological management in dysmenorrhea

Habeeb Unnisa, Prathiba Annam, Naga Chandrika Gubba, Anees Begum, Keerthi Thatikonda

Ann Med Surg (Lond) 2022 Sep; 81: 104407. Published online 2022 Aug 30. doi: 10.1016/j.amsu.2022.104407

PMCID:: PMC9486665

Article PDF–1.4M

Select item 714646811.

Comparative Electroanalytical Studies of Graphite Flake and Multilayer Graphene Paste Electrodes

Natalia Festinger, Kamila Morawska, Vladimir Ivanovski, Magdalena Ziąbka, Katarzyna Jedlińska, Witold Ciesielski, Sylwia Smarzewska

Sensors (Basel) 2020 Mar; 20(6): 1684. Published online 2020 Mar 18. doi: 10.3390/s20061684

PMCID:: PMC7146468

Article PDF–2.7M

Select item 756958312.

Prevalence, attitude and practice of self-medication among adolescents and the paradigm of dysmenorrhea self-care management in different countries

Vincenzo de Sanctis, Ashraf T Soliman, Shahina Daar, Salvatore Di Maio, Rania Elalaily, Bernadette Fiscina, Christos Kattamis

Acta Biomed. 2020; 91(1): 182–192. Published online 2020 Mar 19. doi: 10.23750/abm.v91i1.9242

PMCID:: PMC7569583

Article PDF–563K

Select item 375218913.

Update on Banned Substances 2013

Kenneth P. Barnes, Catherine R. Rainbow

Sports Health. 2013 Sep; 5(5): 442–447. doi: 10.1177/1941738113478546

PMCID:: PMC3752189

Article PDF–526K

Select item 845681114.

Development and validation of a fast ultra‐high‐performance liquid chromatography tandem mass spectrometry method for determining carbonic anhydrase inhibitors and their metabolites in urine and hair

Alfredo Fabrizio Lo Faro, Anastasio Tini, Massimo Gottardi, Filippo Pirani, Ascanio Sirignano, Raffaele Giorgetti, Francesco Paolo Busardò

Drug Test Anal. 2021 Aug; 13(8): 1552–1560. Published online 2021 Jul 16. doi: 10.1002/dta.3055

PMCID:: PMC8456811

Article PDF–2.4M

Select item 903404315.

Validated spectral manipulations for determination of an anti-neoplastic drug and its related impurities including its hazardous degradation product

Ibrahim A. Naguib, Eglal A. Abdelaleem, Eman S. Hassan, Aml A. Emam

RSC Adv. 2021 Jun 15; 11(35): 21332–21342. Published online 2021 Jun 16. doi: 10.1039/d1ra03238k

PMCID:: PMC9034043

Article PDF–1007K

Select item 800118316.

An Emulation of Randomized Trials of Administrating Antipsychotics in PTSD Patients for Outcomes of Suicide-Related Events

Noah R. Delapaz, William K. Hor, Michael Gilbert, Andrew D. La, Feiran Liang, Peihao Fan, Xiguang Qi, Xiaojiang Guo, Jian Ying, Dara Sakolsky, Levent Kirisci, Jonathan C. Silverstein, Lirong Wang

J Pers Med. 2021 Mar; 11(3): 178. Published online 2021 Mar 4. doi: 10.3390/jpm11030178

PMCID:: PMC8001183

Article PDF–1.4M

Select item 853138817.

Prediction of severe adverse events, modes of action and drug treatments for COVID-19’s complications

Courtney Astore, Hongyi Zhou, Joshy Jacob, Jeffrey Skolnick

Sci Rep. 2021; 11: 20864. Published online 2021 Oct 21. doi: 10.1038/s41598-021-00368-6

PMCID:: PMC8531388

Article PDF–1.1M

Select item 392937918.

Analgesic, Anti-Inflammatory, and GC-MS Studies on Castanospermum australe A. Cunn. & C. Fraser ex Hook.

Thankarajan Sajeesh, Thangaraj Parimelazhagan

ScientificWorldJournal. 2014; 2014: 587807. Published online 2014 Feb 2. doi: 10.1155/2014/587807

PMCID:: PMC3929379

Article PDF–599K

Select item 315798919.

Strategies Aimed at Preventing Chronic Post-surgical Pain: Comprehensive Perioperative Pain Management after Total Joint Replacement Surgery

Hance Clarke, Linda J. Woodhouse, Deborah Kennedy, Paul Stratford, Joel Katz

Physiother Can. 2011 Summer; 63(3): 289–304. Published online 2011 Aug 10. doi: 10.3138/ptc.2009-49P

PMCID:: PMC3157989

Article PDF–200K

Select item 609797120.

The Toxicology Investigators Consortium Case Registry—the 2017 Annual Report

Lynn A. Farrugia, Sean H. Rhyee, Sharan L. Campleman, Bryan Judge, Louise Kao, Anthony Pizon, Lauren Porter, Anne M. Riederer, Timothy Wiegand, Diane Calello, Paul M. Wax, Jeffrey Brent, On behalf of the Toxicology Investigators Consortium (ToxIC) Study Group

J Med Toxicol. 2018 Sep; 14(3): 182–211. Published online 2018 Aug 9. doi: 10.1007/s13181-018-0679-z

Correction in:: J Med Toxicol. 2018 Dec; 14(4): 333.

PMCID:: PMC6097971

Article PDF–923K

<< First< Prev

Page of 2

Next >Last >>

Supplemental Content

Filter your results:

All (27)
NIH grants (8)
Embargoed (0)

Manage Filters

PMC Images search for pamabrom

Fig. 3

Forced degradation of API and formulation under various stress condition.
(a) and (b) degradation chromatogram of API and tablets in 1 M HCl at 70° for 4h. Pamabrom peak was observed (peak 2) at R_t of 3.88 min, degradant peak was observed at R_t 3.334 (peak 1) and 4.336 min (peak 3), respectively for both API and tablets. (c) and (d) degradation chromatogram of API and tablets in 1M NaOH at 70° for 2 h. Pamabrom peak was observed (peak 1) at R_t of 3.88 min, degradant peak was observed at R_t 3.41 min (peak 2) for both API and tablets. (e) and (f) degradation chromatogram of API and tablets in 30% H₂O₂ at 40° for 30 min. Pamabrom peak was observed (peak 2) at R_t of 3.88 min, degradant peak was observed at R_t 2.906 min (peak 1) for both API and tablets. (g) and (h) degradation chromatogram of API and formulation in thermal condition at 800 in oven for 5 days. Pamabrom peak was observed (peak 3) at R_t of 3.88 min, degradant peak was observed at R_t 3.1 min (peak 1) and 3.33 min (peak 2), respectively for both API and formulation. (i) and (j) degradation chromatogram of API and tablets in sunlight for 12 days. Pamabrom peak was observed (peak1) at R_t of 3.88 min, no additional peak was observed.

Development and Validation of Stability-indicating RP-HPLC Method for Estimation of Pamabrom in Tablets

Indian J Pharm Sci. 2014 May-Jun;76(3):198-202.
Fig. 1

Chemical structure of pamabrom

Development and Validation of Stability-indicating RP-HPLC Method for Estimation of Pamabrom in Tablets

Indian J Pharm Sci. 2014 May-Jun;76(3):198-202.
Figure 1

Chemical structure of PARA, PAP, and PAMB.

RP-LC and TLC Densitometric Determination of Paracetamol and Pamabrom in Presence of Hazardous Impurity of Paracetamol and Application to Pharmaceuticals

Anal Chem Insights. 2013;8:73-81.
Fig. 2

Standard chromtogram of pamabrom.
Pamabrom peak is seen with a retention time, Rt of 3.88 min.

Development and Validation of Stability-indicating RP-HPLC Method for Estimation of Pamabrom in Tablets

Indian J Pharm Sci. 2014 May-Jun;76(3):198-202.